Award for ImCheck Therapeutics at the Aix-Marseille Innovation Awards
| Leadership & Corporate
ImCheck Therapeutics awarded Innovation Start-up of the Year in Healthcare at the Aix-Marseille Innovation awards.
The…
ImCheck Therapeutics Appoints Prof. René Hoet, PhD, as Chief Scientific Officer
| Science & Medicine
ImCheck Therapeutics, an emerging biopharmaceutical company developing novel immune modulators against cancer and…
ImCheck Therapeutics appoints Dr. Debasish Roychowdhury as its independent Chairman of the Board
| Leadership & Corporate
With over a decade of patient care as a hematologist/oncologist and a career as a big pharma senior executive in R&D,…
ImCheck Therapeutics obtains 1M€ from Bpifrance to contribute to the development of a novel therapeutic antibody in immuno-oncology
| Financial & Business
First non-dilutive funding received by ImCheck following its initial fundraising of 20 M€ in May 2017
ImCheck Therapeutics raises €20 Million and appoints its CEO
| Financial & Business
Emerging leader in immuno-oncology accelerates its development programs and prepares for entry into the clinic